Nutex Health Overview
Latest ROE for Nutex Health: 35.46% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow35.46%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Nutex Health's return on equity stands at 35.46%. That is below the Consumer Staples sector average of 75.63%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Nutex Health sits lower the Consumer Staples benchmark (75.63%) with a ROE of 35.46%. That is roughly 53.1% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A ROE of 35.46% for Nutex Health means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how Nutex Health's ROE evolved across reporting periods, while the comparison chart places NUTX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Consumer Staples, ROE is commonly used to spot outliers. Nutex Health's reading of 35.46% (sector avg 75.63%) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.
